Study comparing vision restoration with collagen cross-linked donor cornea and standard donor cornea

Enter your info and the study team will contact you soon!
Your data is securely stored and only shared with the research team
Data is not saved in preview.
"Boston Keratoprosthesis surgery study (cornea transplant for patients not candidates for traditional corneal transplant)"
Age:
18 to 100 years old
Gender:
Any
Healthy Volunteers:
No
Keywords:
cornea, corneal melting, keratolysis, eye
Type:
Drug study, Phase I/II
Investigator:
Description
The Boston Keratoprosthesis is used in patients who are not candidates for a traditional corneal transplant. This could be because they have had a previous failed corneal transplant or have high likelihood for transplant failure due to a large amount of blood vessels in the cornea. The Boston Keratoprosthesis is assembled using a donated cornea tissue. The donated tissue can thin out in certain patients. Studies have shown that cross-linked corneas are broken down more slowly than corneas that have not been cross-linked. In this study patient will either receive a cross-linked donor cornea before Boston Keratoprosthesis surgery or will receive a standard-of-care non-cross-linked donor cornea. Randomization is like flipping a coin – neither patient, nor physician will know which treatment was received. In either scenario, the donor cornea will be delivered to the surgeon by Tissue Bank International (TBI) at the time of the surgery. The cross-linking procedure has not yet been approved by the United States Food and Drug Administration (FDA) and is therefore considered experimental. The cornea contains a protein called collagen that normally provides stability to the cornea (like the steel beams within a tall building). In this study, we will attempt to form extra connections between the collagen strands to make the cornea tissue stronger before it is used for the Boston Keratoprosthesis implantation. The extra connections, called “cross-links,” are formed by treating the cornea tissue with a special Riboflavin (Vitamin B2) with dextran solution and then carefully exposing it to a measured amount of ultraviolet light. Our goal is to get an indication whether this cross-linking treatment may reduce the rate of cornea thinning or melting.
This study requires
Screening visit for eye exam, pregnancy test if applicable
Boston Keratoprosthesis surgery (corneal transplant for those who are not candidates for traditional corneal transplant) with either: standard donor cornea or a experimental cross-linked (reinforced between collagen strands) for strength
Follow- up visits: Day 1 Week 1, 4, 16, 24, 36, 52, 78 and 104
Who can participate?
Inclusion Criteria:

- Willing and able to provide written informed consent

- Willing and able to comply with study assessments for the full duration of the study

- Age ≥ 18 years

- Candidate for a Boston Keratoprosthesis / Cornea transplant

- In generally good stable overall health

- Patients with an eye at risk for a cornea sterile ulcer which includes:

- Autoimmune diseases (mucus membrane pemphigoid, Stevens-Johnson syndrome, systemic lupus erythematosis, rheumatoid arthritis, or other autoimmune diseases); OR

- History of previous sterile cornea ulceration requiring a cornea transplant


Exclusion Criteria:

- Age < 18 years

- Inability to provide written informed consent and comply with study assessments for the full duration of the study

- No or minimal tear production with evidence of keratinization of the bulbar conjunctiva

- Corneal or ocular surface infection within 30 days prior to study entry

- Ocular or periocular malignancy

- Inability to wear a contact lens due to lid abnormalities or shortened fornix

- Signs of current infection, including fever and current treatment with antibiotics

- Pregnancy (positive pregnancy test) or lactating

- Participation in another simultaneous interventional medical investigation or trial
Resources
Schedule
Study duration and period
2 years
Recruitment period
From Jan. 4, 2017
Location
UC Davis Eye Center
4860 Y Street
Suite 2400
Sacramento, CA 95817
Contact
Mark Mannis, MD
Research Topic
Conditions:
  • Keratolysis

Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.


Sending

Send SMS with Study Info:

SMS Sent!

Share Study Info via Email:


E-mail Preview